Schwartz Aharon 4
4 · Protalix BioTherapeutics, Inc. · Filed Apr 13, 2020
Insider Transaction Report
Form 4
Schwartz Aharon
Director
Transactions
- Purchase
Common Stock
2020-04-07$2.43/sh+64,000$155,264→ 64,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $2.39 to $2.53. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.